Valeo Financial Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,190
Closed -$222K 799
2025
Q4
$222K Buy
+2,190
New +$176K ﹤0.01% 721
2021
Q2
Sell
-1,741
Closed -$229K 933
2021
Q1
$229K Sell
1,741
-124
-7% -$17K 0.01% 413
2020
Q4
$247K Buy
1,865
+1,569
+530% +$190K 0.01% 376
2020
Q3
$30K Sell
296
-15
-5% -$1.29K ﹤0.01% 813
2020
Q2
$27K Sell
311
-130
-29% -$10.4K ﹤0.01% 950
2020
Q1
$29K Sell
441
-2
-0.5% -$162 ﹤0.01% 776
2019
Q4
$41K Buy
443
+269
+155% +$23.6K ﹤0.01% 718
2019
Q3
$16K Sell
174
-9
-5% -$1.02K ﹤0.01% 901
2019
Q2
$22K Sell
183
-6
-3% -$605 ﹤0.01% 817
2019
Q1
$16K Hold
189
﹤0.01% 841
2018
Q4
$12K Hold
189
﹤0.01% 831
2018
Q3
$12K Hold
189
﹤0.01% 912
2018
Q2
$9K Hold
189
﹤0.01% 965
2018
Q1
$8K Hold
189
﹤0.01% 985
2017
Q4
$10K Hold
189
﹤0.01% 834
2017
Q3
$9K Buy
+189
New +$7.61K ﹤0.01% 721

Other funds holding EXAS

Valeo Financial Advisors's EXAS Position: Q1 2026 in Review

Valeo Financial Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,190 shares — an estimated $222K sold.

Valeo Financial Advisors first reported a position in EXAS in Q3 2017 and held it in 16 quarters. The position peaked at $247K in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Valeo Financial Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Valeo Financial Advisors sold 2,190 Exact Sciences shares in Q1 2026, an estimated $222K.
  • Valeo Financial Advisors first reported a position in Exact Sciences in Q3 2017 and held it in 16 quarters.
  • Valeo Financial Advisors's Exact Sciences position peaked at $247K in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Valeo Financial Advisors's 13F filing for Q1 2026, filed 8 May 2026.